Docetaxel

Form: Injection

Strength: 20 mg/0.5 mL, 80 mg/2 mL, 160 mg/4 mL

Reference Brands: Taxotere® (US & EU), Docefrez® (EU)

Category: Oncology Cancer Care

Docetaxel Injection is a widely used cytotoxic chemotherapy drug indicated for breast, lung, prostate, gastric, and head & neck cancers. We offer Docetaxel in EU-GMP and USFDA-compliant injectable formulations, including 20 mg, 80 mg, and 160 mg single-use vials. Available for B2B supply, contract manufacturing, and licensing, our Docetaxel meets global regulatory standards with full CTD dossiers and stability data. Alcohol-free and solvent-based options are available. Ideal for distributors, hospitals, and procurement agencies seeking high-quality oncology products. Partner with us for reliable Docetaxel bulk supply or private label opportunities across Europe, the US, and emerging regulated markets.